![Song Dong Meng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Song Dong Meng
Direktor/Vorstandsmitglied bei Beijing Biostar Pharmaceuticals Co. Ltd.
Aktive Positionen von Song Dong Meng
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | 11.03.2022 | - |
Independent Dir/Board Member | 11.03.2022 | - |
Karriereverlauf von Song Dong Meng
Ausbildung von Song Dong Meng
Chinese Academy of Sciences | Doctorate Degree |
Statistik
International
China | 3 |
Operativ
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Börse
- Insiders
- Song Dong Meng
- Erfahrung